Article
The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD
2024-06-11
Abstract excerpt
Metabolic dysfunction-associated steatotic liver disease is an increasingly prevalent condition, representing a major risk factor for the development of progressive chronic liver damage. This can potentially give rise to the development of steatohepatitis and hepatocellular carcinoma (HCC). It is already known, that patients with metabolic dysfunction-associated steatotic liver disease (MASLD) show increased syste...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 78083f2c-2d3d-596a-8a3e-b7baec7d1b72
- DOI
- 10.1101/2024.06.11.598353
